Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01590615
Recruitment Status : Completed
First Posted : May 3, 2012
Last Update Posted : April 24, 2017
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 4, 2017
  Actual Study Completion Date : April 4, 2017